摘要
目的检测原发性肝癌及其癌旁组织中线粒体DNA含量,探讨线粒体DNA含量变化与肝癌发生的关系。方法荧光实时定量聚合酶链反应(real-time PCR)法扩增22例肝癌及相应癌旁组织中线粒体DNA编码基因细胞色素C氧化酶Ⅱ(COⅡ),以核编码基因磷酸甘油醛脱氢酶(GAPDH)作为内参照,比较两种组织中线粒体DNA含量的差异。结果肝癌组织中线粒体DNA相对含量为156.54±107.54,癌旁组织线粒体DNA相对含量为290.24±187.37,差异有统计学意义(P<0.01)。结论肝癌组织线粒体DNA的含量与肝癌发生有密切关系,有望成为一种新的肝癌标志物。
Objective To detect mitochondrial DNA content changes within hepatocellular carcinoma(HCC) and paracancer liver tissues. Methods Real-time polymerase chain reaction(PCR) was applied to detect the cytochrome C oxidase Ⅱ (CO Ⅱ ) of mitochondrial DNA in 22 cases of HCC and corresponding paracancer liver tissues, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was served as a quantitative standard marker. Results Mitochondrial DNA content of HCC was 156.54±107.54,which was 290.24±187.37 for corresponding paracancer liver tissues( P〈0.01). Conclusion HCC carcinogenesis is closely correlated with mitochondrial DNA content,and it is hopeful as a new tumor marker.
出处
《临床荟萃》
CAS
2010年第1期33-36,共4页
Clinical Focus
基金
国家科技部"十一五"重大专项基金(2008ZX10001-007)
首都医学发展科研基金(207-2050)
关键词
癌
肝细胞
DNA
线粒体
聚合酶链反应
carcinoma, hepatocellular
DNA, mitochondrial
polymerase chain reaction